In this webinar, Dr. Priyaranjan Pattanaik, Head of NBE services at APSL, provides a comprehensive perspective of the ever-evolving science of Antibody Drug Conjugates (ADC).
This webinar gives a review of pathbreaking trends in the field to help you and your team plan your approach for your ongoing and future ADC discovery and development programs.
27 January, 2022
Head, NBE services
Aurigene Pharmaceutical Services Limited is a leading contract research, development and manufacturing organization (CDMO). With a strong legacy of services in discovery, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide.
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.